These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 16986510)
1. [Comparison of TK gene mutation assay in TK6 and TK6-E6 cell induced by vinblastin and colcemid]. Wang YN; Shuai PQ; Ding XQ; Zhang LS Wei Sheng Yan Jiu; 2006 Jul; 35(4):409-11. PubMed ID: 16986510 [TBL] [Abstract][Full Text] [Related]
2. [Analysis of loss of heterozygosity induced by vinblastine at tk locus in human lymphoblastoid cell line TK6]. Wang YN; Shuai PQ; Guo YJ; Zhang LS Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):558-61. PubMed ID: 16909601 [TBL] [Abstract][Full Text] [Related]
3. [Loss of heterozygosity induced by cyclophosphamide at tk locus in human lymphoblastoid cell line TK6]. Zhan L; Zhang LS; Wang L; Zhang H; Takayoshi S; Masamitsu H; Wu DS Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):334-7. PubMed ID: 15931861 [TBL] [Abstract][Full Text] [Related]
4. [TK locus mutation assay: comparison of L5178Y and TK6 cell lines]. Shuai PQ; Zhang LS; Wang YJ Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):650-3. PubMed ID: 15460410 [TBL] [Abstract][Full Text] [Related]
5. Relationship between p53 status and 5-fluorouracil sensitivity in 3 cell lines. Oka H; Ikeda K; Yoshimura H; Ohuchida A; Honma M Mutat Res; 2006 Jul; 606(1-2):52-60. PubMed ID: 16584912 [TBL] [Abstract][Full Text] [Related]
6. Abrogation of p53 function by HPV16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells. Yu Y; Li CY; Little JB Oncogene; 1997 Apr; 14(14):1661-7. PubMed ID: 9135067 [TBL] [Abstract][Full Text] [Related]
7. Baseline levels of chromosome instability in the human lymphoblastoid cell TK6. Schwartz JL; Jordan R; Evans HH; Lenarczyk M; Liber HL Mutagenesis; 2004 Nov; 19(6):477-82. PubMed ID: 15548760 [TBL] [Abstract][Full Text] [Related]
8. Comparison of in vitro micronucleus and gene mutation assay results for p53-competent versus p53-deficient human lymphoblastoid cells. Honma M; Hayashi M Environ Mol Mutagen; 2011 Jun; 52(5):373-84. PubMed ID: 20963812 [TBL] [Abstract][Full Text] [Related]
9. Quantification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human lymphoblastoid TK6 cells dosed with N-hydroxy-4-acetylaminobiphenyl and their relationship to mutation, toxicity, and gene expression profiling. Ricicki EM; Luo W; Fan W; Zhao LP; Zarbl H; Vouros P Anal Chem; 2006 Sep; 78(18):6422-32. PubMed ID: 16970317 [TBL] [Abstract][Full Text] [Related]
10. Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells. Honma M Environ Mol Mutagen; 2005; 45(2-3):162-76. PubMed ID: 15688360 [TBL] [Abstract][Full Text] [Related]
11. Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cells. Carter MM; Torres SM; Cook DL; McCash CL; Yu M; Walker VE; Walker DM Environ Mol Mutagen; 2007; 48(3-4):239-47. PubMed ID: 17358029 [TBL] [Abstract][Full Text] [Related]
12. [The tk gene mutation analysis in WTK1 cell line by multiplex PCR]. Wang YJ; Shuai PQ; Zhang LS Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):790-3. PubMed ID: 17037754 [TBL] [Abstract][Full Text] [Related]
13. A method to distinguish between the de novo induction of thymidine kinase mutants and the selection of pre-existing thymidine kinase mutants in the mouse lymphoma assay. Wang J; Heflich RH; Moore MM Mutat Res; 2007 Jan; 626(1-2):185-90. PubMed ID: 17055776 [TBL] [Abstract][Full Text] [Related]
14. Mutagenic radioadaptation in a human lymphoblastoid cell line. Yatagai F; Umebayashi Y; Honma M; Sugasawa K; Takayama Y; Hanaoka F Mutat Res; 2008 Feb; 638(1-2):48-55. PubMed ID: 17919664 [TBL] [Abstract][Full Text] [Related]
15. [Sensitivity comparison of DNA damage and repair capacity in TK6 and WTK1 cells]. Zhang JQ; Zhang LS; Wang RS Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):767-9. PubMed ID: 15573749 [TBL] [Abstract][Full Text] [Related]
16. Thresholds of nitric oxide-mediated toxicity in human lymphoblastoid cells. Wang C; Trudel LJ; Wogan GN; Deen WM Chem Res Toxicol; 2003 Aug; 16(8):1004-13. PubMed ID: 12924928 [TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger. Meng Q; Su T; O'Neill JP; Walker VE Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380 [TBL] [Abstract][Full Text] [Related]
18. Further characterization of loss of heterozygosity enhanced by p53 abrogation in human lymphoblastoid TK6 cells: disappearance of endpoint hotspots. Yatagai F; Morimoto S; Kato T; Honma M Mutat Res; 2004 Jun; 560(2):133-45. PubMed ID: 15157651 [TBL] [Abstract][Full Text] [Related]
19. Characterization of multilocus lesions in human cells exposed to X radiation and radon. Chaudhry MA; Jiang Q; Ricanati M; Horng MF; Evans HH Radiat Res; 1996 Jan; 145(1):31-8. PubMed ID: 8532834 [TBL] [Abstract][Full Text] [Related]
20. The food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine activates S-phase checkpoint and apoptosis, and induces gene mutation in human lymphoblastoid TK6 cells. Zhu H; Boobis AR; Gooderham NJ Cancer Res; 2000 Mar; 60(5):1283-9. PubMed ID: 10728688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]